首页> 外文期刊>Journal of diabetes investigation. >Association between 1p13 polymorphisms and peripheral arterial disease in a Chinese population with diabetes
【24h】

Association between 1p13 polymorphisms and peripheral arterial disease in a Chinese population with diabetes

机译:中国糖尿病人群1p13基因多态性与外周动脉疾病的关系

获取原文
       

摘要

Aims/Introduction Variants on chromosome 1p13 have been associated with coronary artery disease and acute myocardial infarction risk in different ethnic groups. The present study aimed to investigate the association between 1p13 polymorphisms and the development of peripheral artery disease (PAD) in a Chinese population with type 2 diabetes mellitus. Materials and Methods 1p13 polymorphisms, rs599839, rs646776 and rs12740374, were assessed in a cohort of 882 type 2 diabetes mellitus patients including 440 type 2 diabetes mellitus patients with PAD (DM + PAD group) and 442 patients without PAD (DM group). Genotyping was carried out using TaqMan assay. Results Compared with the DM group, the frequencies of the minor G allele of both rs599839 and rs646776 and the minor T allele of rs12740374 decreased ( P = 0.013, P = 0.019 and P = 0.005, respectively), and the frequencies of rs599839 AG + GG, rs646776 AG + GG and rs12740374 CT+TT genotypes were statistically significantly decreased as well ( P = 0.017, P = 0.011 and P = 0.007, respectively) in the dominant model in the DM + PAD group than in the DM group. Multivariate unconditional logistic regression analyses adjusted for age, glycated hemoglobin, triglyceride, low‐density lipoprotein cholesterol, smoking, hypertension, diabetes duration, coronary heart disease and cerebral infarction showed that the genotypic distribution of rs599839 AG + GG, rs646776 AG + GG and rs12740374 CT + TT remained statistically different between the DM and DM + PAD group ( P = 0.014, P = 0.003 and P = 0.004, respectively). The frequencies of haplotype GGT were statistically significantly different between groups ( P = 0.08). Conclusions The present study strongly supports that genotypes of rs599839, rs646776 and rs12740374 on 1p13 are protective factors for diabetic PAD in a Chinese population. Haplotype GGT generated by rs599839, rs646776 and rs12740374 might also decrease the risk of the disease.
机译:目的/简介在不同种族中,染色体1p13的变异与冠状动脉疾病和急性心肌梗塞风险有关。本研究旨在调查中国2型糖尿病人群1p13基因多态性与周围动脉疾病(PAD)发生的关系。材料和方法在882名2型糖尿病患者中评估了1p13多态性rs599839,rs646776和rs12740374,其中包括440例患有PAD的2型糖尿病患者(DM + PAD组)和442例没有PAD的患者(DM组)。使用TaqMan测定法进行基因分型。结果与DM组相比,rs599839和rs646776的次要G等位基因频率和rs12740374的次要T等位基因频率均降低(分别为P = 0.013,P = 0.019和P = 0.005),而rs599839 AG + DM + PAD组显性模型中的GG,rs646776 AG + GG和rs12740374 CT + TT基因型也显着降低(分别为P = 0.017,P = 0.011和P = 0.007)。校正年龄,糖化血红蛋白,甘油三酸酯,低密度脂蛋白胆固醇,吸烟,高血压,糖尿病病程,冠心病和脑梗死的多元无条件logistic回归分析显示rs599839 AG + GG,rs646776 AG + GG和rs12740374的基因型分布DM组和DM + PAD组之间的CT + TT仍存在统计学差异(分别为P = 0.014,P = 0.003和P = 0.004)。两组之间单倍型GGT的频率在统计学上有显着差异(P = 0.08)。结论本研究强烈支持1p13基因的rs599839,rs646776和rs12740374基因型是中国人群糖尿病PAD的保护因子。 rs599839,rs646776和rs12740374产生的单倍型GGT也可能降低患该病的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号